Orally taken traditional Chinese medicine composition for treating anaphylactoid purpura

Abstract

The invention discloses an oral administration pharmaceutical composition for treating allergic purpura, wherein the active constituents include the following raw material herbs (by weight portion): agkistrodon acutus 16g, rhizome of Sichuan lovage 12g, Chinese angelica root 12g, dried rehmannia root 16g, cicada shell 3g, root of red rooted saliva 16g, root bark of tree peony 12g, cogongrass rhizome 15g, alkanna tinctoria 10g, plaster stone 3g and licorice root 5g. The medicament should be decocted in water for the oral dose.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for oral administration for treating allergic purpura, which belongs to the field of traditional Chinese medicines. Background technique [0002] Henoch-Schonlein purpura is an allergic disease mainly characterized by capillary vasculitis. The main manifestations are skin purpura, gastrointestinal symptoms, joint swelling and pain and urinary system symptoms. More common in children over 5 years old. The etiology of this disease is not yet clear, it may be caused by an allergic reaction caused by a certain sensitizer, but the direct sensitizer is not yet clear. Before the onset, there is often an upper respiratory tract infection caused by hemolytic streptococci, and the onset occurs after an incubation period of 1 to 3 weeks. In addition, viruses such as measles, mumps, etc., parasites such as roundworms, hookworms, etc., food such as eggs, fish, shrimp, etc., drugs such as chloram...

AI Technical Summary

Problems solved by technology

[0011] Hormone and western medicine have relatively large side effects, and now generally prefer traditional Chinese medicine treatment, but there is no specific Chinese medicine preparation at present